Axon Enterprise (NASDAQ: AXON) experienced a 6.5% decline in after-hours trading on Wednesday, settling at $569.90, even after the company reported second-quarter results that surpassed analyst expectations and raised its full-year revenue outlook. The stock had closed the regular session at $609.49, up 0.4%, following a five-day rally of 14.7%.
The market's reaction was driven by the company's updated guidance, which pointed to a moderation in growth during the second half of the year. Axon now projects second-half revenue growth in the range of 29.8% to 33.5%, with a midpoint of 31.7%. This compares to the 35.3% growth reported in the second quarter, signaling a slight deceleration that investors appeared to key in on.
Strong Second Quarter Results
Despite the cautious outlook for H2, Axon's second-quarter performance was robust. Revenue surged 35% year-over-year to $904.4 million, exceeding consensus estimates by 3.3%. Adjusted EBITDA came in at $242.0 million, a 9.8% beat, while adjusted earnings per share of $1.88 topped expectations by 2%. The company's operating margin expanded to 5.2%, a significant improvement from a negative 0.2% in the same period last year.
Segment growth was broad-based. Software and services revenue increased 36% to $398 million, while connected devices grew 35% to $507 million. The AI Era revenue category saw a nearly 700% surge, and Dedrone sales surpassed $100 million, highlighting the company's successful diversification.
Forward Demand Remains Strong
Looking ahead, Axon's forward demand metrics indicate continued momentum. Annual recurring revenue (ARR) climbed 39% to $1.639 billion, with net revenue retention at 126%. Future contracted bookings grew 41% to $15.1 billion, representing approximately 4.1 times the midpoint of the company's projected 2026 revenue. Axon expects to recognize 20%-25% of these bookings within the next 12 months, with the remainder spread over a decade.
However, profitability metrics raised some concerns. Overall gross margin remained flat at 60.4%, with software gross margin declining 430 basis points to 71.3%. Device margins improved by 330 basis points, partly due to tariff refunds. The gap between GAAP and adjusted figures remains wide, with a net margin of just 3.3% versus a 26.8% adjusted EBITDA margin. Stock-based compensation reached $144.3 million, and free cash flow was marginally negative.
Valuation and Analyst Sentiment
Valuation remains a key factor. Axon trades at roughly 12.4 times projected sales and about 50 times guided adjusted EBITDA, based on 80.6 million shares and net debt of $1.1 billion. Its trailing price-to-earnings ratio stands near 244, compared to approximately 35 for rival Motorola Solutions (NYSE: MSI). Analysts remain largely positive, with 21 of 23 rating the stock a buy or overweight, and an average price target of $688.65, implying about 21% upside from after-hours levels.
The company's robust demand and market position justify a premium, but execution will be critical. Investors will closely monitor estimate revisions, software profitability, and backlog conversion in the coming weeks. Axon's steady 25.5% EBITDA margin target underscores the importance of operational efficiency.
In summary, Axon delivered a strong quarter but faces the challenge of sustaining growth at a decelerating pace. The market's reaction suggests that even solid results may not be enough when expectations are elevated. As always, the focus now shifts to the company's ability to convert its substantial backlog into cash flow and GAAP profitability.
